Indeed, residual breast tumors after neoadjuvant chemotherapy comprise an increased frequency of BTIC [17] and overexpress several ABC transporters by comparison to surrounding non-tumor tissue [37]. This evidence concerns the gene ABCG2 and breast neoplasm.